As detailed in Section 3.1, CTSB promotes neurogenesis through the induction of BDNF [86], but also activates lysosomes [206] and has been shown to be neuroprotective in patients with AD by reducing levels of Aβ, though this remains controversial [207,208]. Here, BDNF is linked to Alzheimer disease.